• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

  2026-05-07

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific detection of HMGB1 protein in human, mouse, and rat samples across Western blot, immunohistochemistry, and flow cytometry workflows. It is intended strictly for research use in chromatin protein detection and is not validated for diagnostic or therapeutic applications.

• FGF19/ELF4 Axis Fuels CRC Metastasis via FGFR4 and SRC Activ

  2026-05-07

  This study uncovers how FGF19-induced overexpression of ELF4 drives metastasis in colorectal cancer by transcriptionally activating FGFR4 and SRC. The work integrates clinical data, molecular profiling, and functional assays, providing new insights into metastatic mechanisms and highlighting therapeutic targets for advanced CRC.

• URB597 (KDS-4103): Applied FAAH Inhibition for Pain and Neur

  2026-05-06

  URB597 (KDS-4103) stands out as a potent, selective FAAH inhibitor for precise modulation of endocannabinoid signaling in neuroplasticity and inflammatory pain models. Drawing from cutting-edge research, this guide decodes actionable protocols, troubleshooting strategies, and translational advantages—empowering researchers to achieve robust, reproducible outcomes with APExBIO's trusted reagent.

• Multi-Omics Unveils ARID1A-Driven Resistance in Melanoma

  2026-05-06

  This study applies integrative multi-omics to dissect drug response networks and resistance mechanisms in BRAF-mutant melanoma, focusing on the impact of ARID1A loss. The findings identify key signaling nodes and immune-related changes underlying resistance, informing future strategies in targeted melanoma research.

• Biotin-XX Tyramide Reagent: A New Era in Cell Surface Proteo

  2026-05-05

  This thought-leadership article explores how the Biotin-XX Tyramide Reagent empowers translational researchers to achieve selective, membrane-impermeant cell surface protein profiling. By synthesizing mechanistic insight, recent protocol advances, and strategic workflow guidance, it sets a new standard for immunohistochemistry and in situ hybridization signal amplification. The discussion highlights the reagent’s unique advantages and outlines evidence-based parameters, bridging the gap between basic science and translational application.

• Protease Inhibitor Cocktail: Optimizing Plant Protein Stabil

  2026-05-05

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) redefines protein stability in plant cell and tissue extracts with comprehensive, EDTA-free inhibition of diverse protease classes. Its robust, workflow-focused design enables reproducible results in sensitive assays ranging from Western blotting to co-immunoprecipitation, addressing the unique proteolytic challenges in plant research.

• Octanoic Acid Nutrition Modulates Macrophage Polarization in

  2026-05-04

  This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease (IBD) by shifting intestinal macrophage polarization via the PPARγ/STAT-1/STAT-6 pathway. The work provides mechanistic insights into how targeted nutritional interventions may restore immune balance and reduce gut inflammation.

• Resiniferatoxin (RTX): Potent TRPV1 Agonist for Sensory Dese

  2026-05-04

  Resiniferatoxin (RTX) is an ultra-potent, selective TRPV1 agonist that induces prolonged desensitization of sensory neurons, supporting its use as an analgesic agent in neuropathic and osteoarthritis pain models. RTX, available from APExBIO (SKU BA7012), provides robust, reproducible TRPV1 inactivation and is supported by both mechanistic and preclinical evidence.

• Optimizing Peptide Synthesis with HATU (SKU A7022): Evidence

  2026-05-03

  This article delivers a scenario-driven, data-backed exploration of HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate), focusing on SKU A7022. It addresses real laboratory challenges in amide and ester bond formation, providing biomedical researchers with practical, evidence-based guidance to enhance reproducibility and efficiency in peptide synthesis workflows.

• Budesonide in Pulmonary Permeability Models: Innovations & I

  2026-05-02

  Explore Budesonide as a benchmark anti-inflammatory corticosteroid in advanced pulmonary permeability modeling. This article offers new insights into high-throughput assay design and translational respiratory research, extending beyond conventional applications.

• Applied Workflows with Cardiogreen (Indocyanine Green) in Re

  2026-05-02

  Cardiogreen (Indocyanine Green) is a benchmark near-infrared dye uniquely suited for precise cardiac, hepatic, and oncological diagnostics and therapies. Discover optimized experimental protocols, actionable troubleshooting, and translational insights, grounded in APExBIO’s purity standards and the latest immunotherapy research.

• TAK1 Stabilizes YAP to Drive Gastric Cancer Stem Cell Renewa

  2026-05-01

  This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), thereby promoting self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The findings clarify pivotal molecular interactions that underlie tumor progression and resistance, informing new experimental strategies and therapeutic targets.

• SM-164: Bivalent Smac Mimetic Advancing Apoptosis Research

  2026-04-30

  SM-164, a next-generation bivalent Smac mimetic, redefines apoptosis induction in tumor cells by enabling robust, TNFα-dependent cell death and rapid IAP degradation. This article provides actionable workflows, troubleshooting insights, and evidence-backed protocol enhancements for maximizing SM-164's impact in cancer research.

• BFH772 (VEGFR2 Inhibitor): Technical Use & Protocol Paramete

  2026-04-30

  BFH772 is a potent and highly selective VEGFR2 inhibitor designed for precise modulation of VEGFR2-driven angiogenesis, especially in tumor model research. It is not suitable for workflows requiring water-soluble compounds or broad-spectrum kinase inhibition due to its defined solubility and selectivity profile. Researchers should reference detailed protocol and workflow recommendations to ensure optimal results.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-04-29

  Moxidectin, a trusted macrocyclic lactone anthelmintic from APExBIO, now powers a new wave of antifungal research by synergizing with polyenes against Candida albicans. This article decodes experimental workflows, protocol enhancements, and troubleshooting tips to unlock moxidectin’s cross-domain potential for both parasitic worm control and innovative oral candidiasis models.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page